Ester Falconer - Jun 9, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Technology Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 9, 2021
Transactions value $
-$25,500,000
Form type
4
Date filed
6/10/2021, 05:00 PM
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Sale -$25.5M -1M -100% $25.50 0 Jun 9, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.